The campaign for global immunization against the SARS-CoV-2 virus is proving tougher than everyone anticipated. The simple reason is that the world was never prepared for something like this. A combination of underfunded and disjointed health systems, dwindling vaccine supplies, and emerging variants compromising the efficacy of the available vaccines have complicated the roll-out for most countries, with many others being unable to even begin as the richest horde stock.
This week on AIAC Talk, we’re looking at both the successes (and shortcomings) of how places in Asia and the Pacific (like Bhutan, Vietnam, Japan and the Indian state of Kerala) responded to COVID-19, widely praised as avoiding the false dichotomy of saving lives or saving livelihoods. We are interested in developing a comparative perspective that refrains from oversimplifying it to a single factor. To help us assess these countries varied efforts we’ll be joined Sakiko Fukuda-Parr, a development economist and professor of International Affairs at The New School, where her teaching and research have focused on human rights and development as well as global health.
